Search

Search Constraints

You searched for: Author/Creator Rabin, Neil

Search Results

1. Long term outcomes in monoclonal gammopathy of renal significance. (29th May 2019)

3. Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy. (10th June 2020)

5. Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. (6th August 2019)

7. Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients. Issue 12 (15th October 2021)

8. Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience. Issue 14 (6th December 2021)

9. Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study. Issue 1 (January 2022)

10. Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019. (15th February 2022)